Zhejiang Bio Pharmaceutical Technology

Zhejiang Bio-Pharma is a China-based pharmaceutical company specializing in the research, development, and manufacturing of both small molecule drugs and biologics. The company maintains a diverse portfolio focusing on metabolic diseases, particularly diabetes and obesity, as well as infectious diseases. In addition to its proprietary drug pipeline, Zhejiang Bio-Pharma operates as a contract development and manufacturing organization (CDMO), providing high-quality active pharmaceutical ingredients (APIs) and finished dosage forms to global markets. The company is recognized for its integrated manufacturing capabilities that adhere to international GMP standards, supporting its mission to provide affordable and innovative healthcare solutions.